亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Save the foreskin: Outcomes of preputioplasty in the treatment of childhood phimosis

医学 包皮 美容 外科 龟头炎 病态的 内科学 遗传学 生物 细胞培养
作者
Sesi Hotonu,Ahmed Osama Mohamed,Ashok Rajimwale,Milan Gopal
出处
期刊:Surgeon-journal of The Royal Colleges of Surgeons of Edinburgh and Ireland [Elsevier BV]
卷期号:18 (3): 150-153 被引量:3
标识
DOI:10.1016/j.surge.2019.08.004
摘要

Symptomatic phimosis is a common childhood urology complaint. Circumcision was traditionally the treatment of choice, but its popularity in cases of non-scarred phimosis has been superseded by more conservative methods like preputioplasty. We sought to examine outcomes of preputioplasty for the treatment of non-scarred pathological phimosis in two UK paediatric surgery tertiary centres. Retrospective case series selecting cases performed in both departments over a 4 year period (January 2012–December 2015). Inclusion criteria: non-scarred pathological phimosis treated with preputioplasty. Exclusion criteria: diffuse scarring of foreskin or presence of balanitis xerotica obliterans (BXO), preputioplasty performed as part of hypospadias repair. Outcome measure was treatment success as evidenced by fully retractile prepuce at follow up. Follow up occurred between 3 and 24 months. We identified 126 patients, 6 were excluded due to the above criteria. Median age was 13.4 years (range 10 months–18 years). Median follow up was 13 months (range 3–24 months). 115 patients (96%) had successful treatment as evidenced by satisfactory post-operative cosmesis and complete resolution of phimosis at follow up. Recurrence of phimosis occurred in 5 patients (4%). Mean time of recurrence was 6 months, with a median age of recurrence of 15.3 years (range 10.7–16.7 years). All patients with recurrence were successfully treated with circumcision. Foreskin conserving methods like preputioplasty are a valid option in the treatment of non-scarred pathological phimosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kepiaaaaaaa应助程平采纳,获得20
刚刚
脑洞疼应助LLL采纳,获得10
1秒前
2秒前
6秒前
12秒前
充电宝应助mmyhn采纳,获得10
12秒前
轻松含双应助彭蓬采纳,获得10
12秒前
yangtao完成签到,获得积分10
13秒前
燕烟完成签到,获得积分10
14秒前
Meteor636完成签到 ,获得积分10
15秒前
AX完成签到,获得积分10
15秒前
minikk发布了新的文献求助20
16秒前
燕烟发布了新的文献求助10
18秒前
Amierx完成签到 ,获得积分10
18秒前
爆米花应助机智的板栗采纳,获得10
23秒前
24秒前
大知闲闲完成签到 ,获得积分10
29秒前
彭蓬发布了新的文献求助10
31秒前
聪明的冥茗完成签到 ,获得积分10
44秒前
45秒前
蛋挞公主完成签到,获得积分10
48秒前
立冬发布了新的文献求助10
51秒前
53秒前
脑洞疼应助火星上听寒采纳,获得10
56秒前
Cupid发布了新的文献求助10
56秒前
思源应助大气靳采纳,获得10
57秒前
minikk完成签到,获得积分10
59秒前
强健的若云完成签到 ,获得积分10
59秒前
Jack发布了新的文献求助10
1分钟前
清爽的如波完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
Cupid完成签到,获得积分10
1分钟前
Akim应助OnlyHarbour采纳,获得10
1分钟前
龙猫抱枕完成签到,获得积分10
1分钟前
1分钟前
小二郎应助吃道格的恺特采纳,获得10
1分钟前
maoke完成签到 ,获得积分10
1分钟前
晓生完成签到,获得积分10
1分钟前
高分求助中
Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens, 7th edition 1000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
Signals, Systems, and Signal Processing 610
脑电大模型与情感脑机接口研究--郑伟龙 500
GMP in Practice: Regulatory Expectations for the Pharmaceutical Industry 500
简明药物化学习题答案 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6299032
求助须知:如何正确求助?哪些是违规求助? 8116104
关于积分的说明 16990807
捐赠科研通 5360255
什么是DOI,文献DOI怎么找? 2847594
邀请新用户注册赠送积分活动 1825062
关于科研通互助平台的介绍 1679354